ONYX PHARMACEUTICALS INC Increase (Decrease) in Accounts Receivable
ONYX PHARMACEUTICALS INC reported Increase (Decrease) in Accounts Receivable of $52.19 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2013-06-30 was -$1.33M, a 118.46% decline year-over-year.
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2013-03-31 was $53.52M.
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2012-12-31 was $53.67M, a 18279.79% increase year-over-year.
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was $21.67M, a 220.06% increase year-over-year.
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2012 was $79.12M, a 1111.78% increase from fiscal 2011.
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2011 was $6.53M.
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2010 was -$6.00K, a 100.04% decline from fiscal 2009.
- ONYX PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2009 was $15.58M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $52.19M 10-Q · filed 2013-08-09 | $105.86M derived: sum of 3 quarters · filed 2013-08-09 | $127.53M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $53.52M 10-Q · filed 2013-05-08 | $107.19M derived: sum of 2 quarters · filed 2013-05-08 | $128.86M derived: sum of 3 quarters · filed 2013-05-08 | $136.04M derived: sum of 4 quarters · filed 2013-05-08 |
| 2012-12-31 | $53.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $75.34M derived: sum of 2 quarters · filed 2013-02-28 | $82.52M derived: sum of 3 quarters · filed 2013-02-28 | $79.12M 10-K · filed 2013-02-28 |
| 2012-09-30 | $21.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $28.85M derived: sum of 2 quarters · filed 2012-11-02 | $25.45M 10-Q · filed 2012-11-02 | $25.74M derived: sum of 4 quarters · filed 2012-11-02 |
| 2012-06-30 | $7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $3.78M 10-Q · filed 2012-08-06 | $4.07M derived: sum of 3 quarters · filed 2012-08-06 | $10.84M derived: sum of 4 quarters · filed 2012-08-06 |
| 2012-03-31 | -$3.40M 10-Q · filed 2012-05-04 | -$3.11M derived: sum of 2 quarters · filed 2012-05-04 | $3.66M derived: sum of 3 quarters · filed 2012-05-04 | $3.69M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-12-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $7.06M derived: sum of 2 quarters · filed 2012-02-27 | $7.09M derived: sum of 3 quarters · filed 2012-08-06 | $6.53M 10-K · filed 2012-02-27 |
| 2011-09-30 | $6.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $6.80M derived: sum of 2 quarters · filed 2012-08-06 | $6.24M 10-Q · filed 2011-11-03 | $10.73M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$533.00K 10-Q · filed 2012-08-06 | $3.96M derived: sum of 3 quarters · filed 2012-08-06 | -$1.42M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-03-31 | -$566.00K 10-Q · filed 2012-05-04 | $3.93M derived: sum of 2 quarters · filed 2012-05-04 | -$1.45M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$882.00K derived: sum of 2 quarters · filed 2012-02-27 | -$6.00K 10-K · filed 2012-02-27 | |
| 2010-09-30 | -$5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$4.50M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $876.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $15.58M 10-K · filed 2012-02-27 |